References
- SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
- ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
- WeissRBDonehowerRCWiernikPHHypersensitivity reactions from taxolJ Clin Oncol199087126312681972736
- SosnikAReversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “generally recognized as safe” (GRAS) nanopharmaceuticals: a reviewAdv Drug Deliv Rev20136513–141828185124055628
- ZhuXLiYXieCmiR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6Int J Cancer201413561286129624510775
- SilvaRVilas-BoasVCarmoHModulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategyPharmacol Ther2015149112325435018
- SaxenaVHussainMDPolymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancerJ Biomed Nanotechnol2013971146115423909128
- SinghMSLamprechtACargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicinInt J Pharm2015478274575225437111
- PatelKPatilAMehtaMGotaVVaviaPMedium chain triglyceride (MCT) rich, paclitaxel loaded self nanoemulsifying preconcentrate (PSNP): a safe and efficacious alternative to taxolJ Biomed Nano-technol201391219962006
- ShiYvan der MeelRTheekBComplete regression of xenograft tumors upon targeted delivery of paclitaxel via Pi-Pi stacking stabilized polymeric micellesACS Nano2015943740375225831471
- FuHShiKHuGTumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol)J Pharm Sci201510431160117325449709
- BaekJChoCControlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticlesInt J Pharm2014478261762425510604
- ShapiraALivneyYDBroxtermanHJAssarafYGNanomedicine for targeted cancer therapy: towards the overcoming of drug resistanceDrug Resist Updat201114315016321330184
- YanFZhangCZhengYThe effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine20106117017819447200
- TranTHNguyenCTGonzalez-FajardoLLong circulating self-assembled nanoparticles from cholesterol-containing brush-like block copolymers for improved drug delivery to tumorsBiomacromolecules201415114363437525310277
- LancelotASierraTSerranoJLNanostructured liquid-crystalline particles for drug deliveryExpert Opin Drug Deliv201411454756424490701
- DrazMSFangBAZhangPNanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infectionsTheranostics20144987289225057313
- YinRXYangDZWuJZNanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosisTheranostics20144217520024465275
- WuYPChuQTanSWD-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel deliveryInt J Nanomed20151052195235
- SrivatsanAChenXRecent advances in nanoparticle-based nuclear imaging of cancersAdv Cancer Res20141248312925287687
- ChoiKYSilvestreOFHuangXA nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivoNat Protoc2014981900191525033207
- JeongBBaeYHKimSWDrug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymersJ Control Release2000631–215516310640589
- ZhangKTangXZhangJPEG-PLGA copolymers: their structure and structure-influenced drug delivery applicationsJ Control Release2014183778624675377
- MenonJUJadejaPTambePVuKYuanBNguyenKTNano-materials for photo-based diagnostic and therapeutic applicationsTheranostics20133315216623471164
- KirtaneARKalscheuerSMPanyamJExploiting nanotechnology to overcome tumor drug resistance: challenges and opportunitiesAdv Drug Deliv Rev20136513–141731174724036273
- WanCPLetchfordKLeungDJacksonJKBurtHMMixed molecular weight copolymer nanoparticles for the treatment of drug-resistant tumors: formulation development and cytotoxicityJ Pharm Sci2014103123966397625318668
- MudraDRBorchardtRTAbsorption barriers in the rat intestinal mucosa. 3: effects of polyethoxylated solubilizing agents on drug permeation and metabolismJ Pharm Sci20109921016102719650119
- LiMSiLPanHExcipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusionInt J Pharm20114031–2374520969937
- ShenJYinQChenLZhangZLiYCo-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancerBiomaterials201233338613862422910221
- BaoYLGuoYYZhuangXTD-α-tocopherol polyethylene glycol succinate-based redoxSensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cellsMol Pharm20141193196320925102234
- ZhouPAnTZhaoCLactosylated PLGA nanoparticles containing ε-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteinsInt J Pharm2015478263364325510599
- Moreno-SanzGBarreraBArmirottiAStructural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brainPharmacol Res201487879324993496
- FengSS15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: original research article: a novel controlled release formulation for the anticancer drug paclitaxel (taxol): PLGA nanoparticles containing vitamin E TPGS (2003)J Control Release2014190586025356488
- ZengXTaoWMeiLHuangLTanCFengSSCholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancerBiomaterials201334256058606723694904
- SunYYuBWangGEnhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxelColloids Surf B Biointerfaces201412371672325456995
- KimSYHwangJSeoJShinUSProduction of CNT-taxol-embedded PCL microspheres using an ammonium-based room temperature ionic liquid: as a sustained drug delivery systemJ Colloid Interface Sci201544214715325527087
- NaeemMKimWCaoJJungYYooJWEnzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colonColloids Surf B Biointerfaces201412327127825266978
- ZhangPHuLWangYWangJFengLLiYPoly(epsilon-caprolactone)-block-poly(ethyl ethylene phosphate) micelles for brain-targeting drug delivery: in vitro and in vivo valuationPharm Res201027122657266920848303
- ZhangWShiYChenYEnhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistanceEur J Pharm Biopharm201075334135320451605
- GuoYYWangDSongQLErythrocyte membrane-enveloped polymeric nanoparticles as nano-vaccine for induction of antitumor immunity against melanomaACS Nano2015976918693326153897
- BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
- YuYTanSZhaoSAntitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification techniqueInt J Nanomed2013826412652
- EetezadiSEkdawiSNAllenCThe challenges facing block copolymer micelles for cancer therapy: In vivo barriers and clinical translationAdv Drug Deliv Rev20159172225308250